Raltegravir Added to Stable HAART in HIV-1 Infected Subjects With Viral Suppression and Low CD4 Recovery

NCT00562510 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

20

Enrollment

OTHER

Sponsor class

Stopped recruitment lower than estimated

Conditions

HIV Infections

Interventions

DRUG: Raltegravir
DRUG: Placebo

Sponsor

Pedro Cahn

Collaborators

[object Object]